JP2023533871A5 - - Google Patents
Info
- Publication number
- JP2023533871A5 JP2023533871A5 JP2023503113A JP2023503113A JP2023533871A5 JP 2023533871 A5 JP2023533871 A5 JP 2023533871A5 JP 2023503113 A JP2023503113 A JP 2023503113A JP 2023503113 A JP2023503113 A JP 2023503113A JP 2023533871 A5 JP2023533871 A5 JP 2023533871A5
- Authority
- JP
- Japan
- Prior art keywords
- unit
- fusion polypeptide
- antigen
- expression
- expression vector
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20185743 | 2020-07-14 | ||
| EP20185743.0 | 2020-07-14 | ||
| EP20207526.3 | 2020-11-13 | ||
| EP20207526 | 2020-11-13 | ||
| EP21171319.3 | 2021-04-29 | ||
| EP21171319 | 2021-04-29 | ||
| PCT/EP2021/069582 WO2022013277A1 (en) | 2020-07-14 | 2021-07-14 | Apc targeting units for immunotherapy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023533871A JP2023533871A (ja) | 2023-08-04 |
| JP2023533871A5 true JP2023533871A5 (cg-RX-API-DMAC10.html) | 2024-07-19 |
Family
ID=79555093
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023503113A Pending JP2023533871A (ja) | 2020-07-14 | 2021-07-14 | 免疫療法のためのapc標的化単位 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20230355733A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4181949A1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2023533871A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2021307553A1 (cg-RX-API-DMAC10.html) |
| CA (1) | CA3183951A1 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2022013277A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL308310A (en) | 2021-05-10 | 2024-01-01 | Nykode Therapeutics ASA | Co-expression of immune-stimulating structures and compounds |
| US20250304626A1 (en) | 2021-05-26 | 2025-10-02 | Evaxion Biotech A/S | Vaccination targeting intracellular pathogens |
| CN114106207B (zh) * | 2022-01-24 | 2022-04-26 | 诺未科技(北京)有限公司 | Ccl5的用途 |
| WO2024092025A1 (en) | 2022-10-25 | 2024-05-02 | Nykode Therapeutics ASA | Constructs and their use |
| US20260193669A1 (en) | 2022-11-09 | 2026-07-09 | Nykode Therapeutics ASA | Co-Expression of Constructs and Polypeptides |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2485400A1 (en) * | 2002-05-10 | 2003-11-20 | Inex Pharmaceuticals Corporation | Methylated immunostimulatory oligonucleotides and methods of using the same |
| AU2013224658A1 (en) * | 2006-07-21 | 2013-09-19 | California Institute Of Technology | Targeted gene delivery for dendritic cell vaccination |
| WO2011161244A1 (en) * | 2010-06-25 | 2011-12-29 | Vaccibody As | Homodimeric protein constructs |
| JP2014534807A (ja) * | 2011-09-23 | 2014-12-25 | ユニバーシティ オブ オスロUniversity of Oslo | クロスプレゼンテーションを行う樹状細胞を標的としたワクチボディ |
| JP7114477B2 (ja) | 2015-12-16 | 2022-08-08 | グリットストーン バイオ インコーポレイテッド | 新生抗原の特定、製造、および使用 |
| JP2019505512A (ja) * | 2016-01-08 | 2019-02-28 | バッシボディ アクスイェ セルスカプ | 治療用抗癌ネオエピトープワクチン |
| US20180161412A1 (en) * | 2016-12-14 | 2018-06-14 | Cyvax, Inc. | Extended protection protein vaccines against infectious agents |
| AU2018254526B2 (en) | 2017-04-19 | 2024-02-15 | Seattle Project Corp. | Neoantigen identification, manufacture, and use |
| WO2018201017A1 (en) * | 2017-04-27 | 2018-11-01 | Washington University | Dendritic cell targeted adenovirus for vaccination |
| CN111465989B (zh) | 2017-10-10 | 2024-06-25 | 磨石生物公司 | 使用热点进行的新抗原鉴别 |
| AU2018373154B2 (en) | 2017-11-22 | 2025-08-07 | Seattle Project Corp. | Reducing junction epitope presentation for neoantigens |
| CN113423419A (zh) * | 2019-01-04 | 2021-09-21 | 桑格摩生物治疗股份有限公司 | 用于治疗法布里病的方法和组合物 |
| AU2021253641B2 (en) * | 2020-04-07 | 2026-08-06 | Evaxion Biotech A/S | Neoepitope immunotherapy with APC targeting unit |
-
2021
- 2021-07-14 WO PCT/EP2021/069582 patent/WO2022013277A1/en not_active Ceased
- 2021-07-14 US US18/004,889 patent/US20230355733A1/en active Pending
- 2021-07-14 CA CA3183951A patent/CA3183951A1/en active Pending
- 2021-07-14 EP EP21742837.4A patent/EP4181949A1/en active Pending
- 2021-07-14 JP JP2023503113A patent/JP2023533871A/ja active Pending
- 2021-07-14 AU AU2021307553A patent/AU2021307553A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023521722A5 (cg-RX-API-DMAC10.html) | ||
| JP7578938B2 (ja) | B7-h3に対するモノクローナル抗体および細胞治療におけるその使用 | |
| JP7190528B2 (ja) | 神経膠芽腫を治療するための細胞透過性ペプチド、カーゴ、及びtlrペプチドアゴニストを含む新規複合体 | |
| US8097257B2 (en) | MAGE3 polypeptides | |
| CA2687395C (en) | Complement factor h-derived short consensus repeat-antibody constructs | |
| JP2022529989A (ja) | フラジェリン融合タンパク質及びその使用 | |
| AU2008310313C1 (en) | A method of transfection and compositions therefor | |
| RU2677799C2 (ru) | Модифицированные суперспиральные белки с улучшенными свойствами | |
| KR20190057345A (ko) | 암 치료를 위한, 세포 투과 펩타이드, 멀티 에피토프 및 tlr 펩타이드 작용제를 포함하는 융합체 | |
| IL278418B2 (en) | Vaccine composition | |
| HU228382B1 (en) | Vaccine composition | |
| US11352416B2 (en) | Mosaic chimeric viral vaccine particle | |
| JP2023522588A5 (cg-RX-API-DMAC10.html) | ||
| JP2023533871A (ja) | 免疫療法のためのapc標的化単位 | |
| WO2024222926A1 (zh) | 可自组装为纳米颗粒的融合蛋白及其在免疫中的应用 | |
| JP2023521722A (ja) | Apc標的化単位を用いたネオエピトープ免疫療法 | |
| JP6873530B2 (ja) | 自己組織化合成タンパク質(Self−Assembling Synthetic Proteins) | |
| JP2006505252A (ja) | 抗原およびアジュバントの多量体複合体 | |
| US10507236B2 (en) | Chimeric proteins | |
| JP2023546485A (ja) | Pd-l1の細胞外ドメインを含むキメラ抗原 | |
| JP2023546298A5 (cg-RX-API-DMAC10.html) | ||
| Gor et al. | Genetic fusion of three tandem copies of murine C3d sequences to diphtheria toxin fragment B elicits a decreased fragment B-specific antibody response | |
| US20100129383A1 (en) | Bifunctional fusion molecules for the delivery of antigens to professional antigen-presenting cells | |
| CN115197303B (zh) | 一种s蛋白的受体结合结构域的突变体及其应用 | |
| JP7513303B2 (ja) | 腫瘍免疫増強剤、その調製方法および適用 |